SOCS2
SOCS2 (suppressor of cytokine signalling 2, also known as SSI-2, CIS2 or STATI2) is a cytoplasmic member of the SOCS family of negative regulators of cytokine receptor signalling. It acts as a substrate-recognition component of a cullin-5 E3 ubiquitin ligase complex. Browse Assay Genie's current range of SOCS2 research reagents below, or read on for the biology behind the target.
SOCS2 is a substrate-recognition component of a cullin-5-RING E3 ubiquitin-protein ligase complex, known as the ECS or CRL5 complex. Through its SH2 domain, it specifically recognises and binds phosphorylated proteins, promoting their ubiquitination and subsequent proteasomal degradation. The ECS(SOCS2) complex is a key regulator of growth hormone receptor (GHR) levels: it ubiquitinates and degrades GHR after the receptor has been phosphorylated by JAK2. It also catalyses ubiquitination and degradation of JAK2-phosphorylated EPOR, the erythropoietin receptor.
The SOCS2 gene encodes a member of the suppressor of cytokine signalling family. SOCS proteins are cytokine-inducible negative regulators of cytokine receptor signalling through the JAK/STAT pathway. They interact with major molecules of signalling complexes to block further signal transduction, in part by proteasomal depletion of receptors or signal-transducing proteins via ubiquitination. Expression of the SOCS2 gene can be induced by a subset of cytokines, including erythropoietin, GM-CSF, IL-10 and interferon-gamma, and by cytokine receptors such as the growth hormone receptor. The protein is also reported to interact with the cytoplasmic domain of the insulin-like growth factor-1 receptor (IGF1R) and is thought to be involved in regulating IGF1R-mediated cell signalling.
HGNC places SOCS2 in the SH2 domain containing group and the suppressors of cytokine signalling group. Aliases include STATI2, SSI2, SOCS-2, SSI-2, CIS2 and Cish2. The gene has pseudogenes on chromosomes 20 and 22, and alternative splicing produces multiple transcript variants. Mouse and rat each have an ortholog named Socs2.
SOCS2 is a cytokine-inducible negative regulator of receptor signalling through the JAK/STAT pathway, making it a model for feedback control.
The ECS(SOCS2) complex ubiquitinates JAK2-phosphorylated GHR and drives its degradation, regulating receptor levels.
SOCS2 serves as an SH2-based substrate-recognition component of a cullin-5-RING E3 ligase, targeting phosphorylated proteins for proteasomal degradation.
SOCS2 promotes degradation of JAK2-phosphorylated EPOR and interacts with IGF1R, linking it to erythropoietin and insulin-like growth factor signalling.
SOCS2 is the substrate-recognition subunit of a cullin-5 E3 ubiquitin ligase complex. Its SH2 domain binds phosphorylated proteins such as JAK2-phosphorylated GHR and EPOR, promoting their ubiquitination and proteasomal degradation, which dampens cytokine receptor signalling.
SOCS2 is also called STATI2, SSI2, SOCS-2, SSI-2, CIS2 and Cish2. NCBI Gene reports that alternative splicing of the SOCS2 gene results in multiple transcript variants, and that pseudogenes exist on chromosomes 20 and 22.
Yes. Mouse and rat both have a Socs2 ortholog. SOCS2 belongs to the wider SOCS family, which includes SOCS1 and SOCS3; check the datasheet of any product for its validated reactivity.
Other members of the SOCS family that regulate cytokine receptor signalling through the JAK/STAT pathway.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O14508; product specifications from Assay Genie datasheets.